Glucokinase activator

Details for Australian Patent Application No. 2008225613 (hide)

Owner KYORIN PHARMACEUTICAL CO., LTD. TEIJIN Pharma Limited

Inventors Ohata, Kohei; Ide, Tomohiro; Kobayashi, Shinji; Asahina, Yoshikazu; Fukuda, Yasumichi; Komatsu, Kanji; Takadoi, Masanori; Yamamoto, Masanori; Kobayashi, Fumiyoshi

Agent Griffith Hack

Pub. Number AU-B-2008225613 (Modified Examination)

PCT Pub. Number WO2008/111473

Priority 2007-336466 27.12.07 JP; 2007-057427 07.03.07 JP

Filing date 6 March 2008

Wipo publication date 18 September 2008

Acceptance publication date 14 June 2012

International Classifications

C07D 213/75 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

A61K 31/415 (2006.01) - 1,2-Diazoles

A61K 31/421 (2006.01) - 1,3-Oxazoles, e.g. pemoline, trimethadione

A61K 31/426 (2006.01) - 1,3-Thiazoles

A61K 31/433 (2006.01) - Thiadiazoles

A61K 31/437 (2006.01)

A61K 31/4965 (2006.01) - Non-condensed pyrazines

A61P 3/04 (2006.01) Drugs for disorders of the metabolism

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07D 231/38 (2006.01) Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings

C07D 241/20 (2006.01) Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings

C07D 263/14 (2006.01) Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings

C07D 277/20 (2006.01) Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

C07D 277/46 (2006.01) Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

C07D 277/56 (2006.01) Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

C07D 285/12 (2006.01) Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups

C07D 405/04 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 405/12 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 417/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

C07D 498/04 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 513/04 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or

Event Publications

10 September 2009 PCT application entered the National Phase

  PCT publication WO2008/111473 Priority application(s): WO2008/111473

14 June 2012 Application Accepted

  Published as AU-B-2008225613 (Modified Examination)

11 October 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008225731-Use of tocopherol

2008225564-Method for test on integrity of microporous membrane